Research study Program year 2023 Source: CMS Open Payments

A Phase III Randomized Double Blind Placebo Controlled Multicenter Study to Evaluate the Efficacy

Research payments

$714,553

247 payments

Through program year 2023, $714,553 in research payments was reported against A Phase III Randomized Double Blind Placebo Controlled Multicenter Study to Evaluate the Efficacy, across 247 payments.

Paid by (largest first): Roche Products Limited; F. Hoffmann-La Roche AG; Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$406	5
2021	Research	$132,032	61
2020	Research	$285,394	120
2019	Research	$296,720	61

Breakdown

Who paid Research payments · program years 2019–2023

Roche Products Limited $712,165 239 payments
F. Hoffmann-La Roche AG $1,981 3 payments
Genentech, Inc. $406 5 payments

Who received the money Research payments · program years 2019–2023

Great Falls Clinic Mercury Street Medical Organisation paid for research $90,331 13 payments
Washington University At St Louis Organisation paid for research $77,216 24 payments
Wayne State University School O Organisation paid for research $56,434 20 payments
The Medical College Of Wisconsin INC Organisation paid for research $38,307 12 payments
Regents Of The University Of California Ucsd Organisation paid for research $30,681 9 payments
Uc Davis Medical Center Teaching hospital · CA $30,131 7 payments
Salem Research Institute INC Organisation paid for research $29,875 12 payments
University Of Vermont Medical Center Teaching hospital · VT $28,120 11 payments
Infectious Disease Specialists Pc Organisation paid for research $26,166 8 payments
Temple University Organisation paid for research $24,745 8 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.